Background: Bovine viral diarrhea, caused by bovine viral diarrhea virus (BVDV), has been considered a disease of cattle but is now emerging in camels. In Ethiopia it has been detected in exotic and cross-bred dairy cattle but no information is available on its occurrence in indigenous cattle breeds and camels. This study was, therefore, conducted to estimate the prevalence of BVDV infection in indigenous Borana cattle and camels (Camelus dromedarius) in Moyale and Miesso pastoral districts. Methodology: Serological investigation was carried out on 219 cattle from 44 herds and 137 camels from 11 herds in contact with the selected cattle herds in Boranara zone and 348 camels from 41 herds in Shinille zone. The sera samples were tested using a competitive enzyme lnked immunosorbent assay (c-ELISA) to detect antibodies against p80 protein of BVDV. In addition, all of the cattle sera were tested using antigen detection ELISA for identification of persistent infection. Results: Among the 219 cattle tested, 177 (80.82%; 95% CI: 74.97-85.81) were found to be positive for antibodies against BVDV in Moyale district, Borena Zone. The prevalence varied among different age groups and parity. The highest prevalence was observed in cattle aged 8 years and older (84.0%; 95% CI: 69.6-98.4) and in primiparous cattle (85.5%; 95% CI: 76.2-94.8). Two of the 219 cattle tested (0.05%; 95% CI: 0.02-0.08) were found to be positive with antigen detection ELISA. In addition, out of a total of 137 camels tested, two (1.46%; 95% CI: 0.18-5.17) were found to be positive in this district. Among the 348 camels tested, eight (2.29%; 95% CI: 0.99-4.485) were found to be positive for antibodies against BVDV. In conclusion, this study revealed a high prevalence of infection in Borana cattle. In addition, it recorded the occurrence of infection with BVDV in camel herds. None of the camels tested positive for the antigen of BVDV using antigen ELISA.

No abstract

Combination of Cross-sectional and retrospective study was conducted from Jan 2021 up to Jun 2021 in Jigjiga city Municipal abattoir and inventory of pharmaceutical drug shops, with the objectives of determining the prevalence of bovine cysticercosis and treatment costs of human taeniasis. Systematic random sampling technique was employed for selecting the study animals, while the Sampling methodology was based on Active abattoir survey and Inventory of pharmaceutical drug shops. From the 520 animals examined at abattoir, the overall prevalence of cysticercus bovis was 2.69% (14/520) with 95% CI of (1.43, 4.29). There was no statistically significant difference in sex, age, body condition score and origin of the animal with the occurrence of C. bovis (P>0.05); From 14 infected cattle with cysticercus bovis, 7 (50%) of cysticercus bovis were in the triceps muscle, 5 (35.71%) in tongue, 1 (7.14%) in biceps muscle and 1 (7.14%) in masseter muscle. Descriptive statistics revealed that a total of 23,063 doses of taenicidal drugs concern a 4-year period (2017-2020) were used for the treatment of human taeniasis which worth 56,933 Ethiopian Birr in the town. Albendazole was employed at a rather high dose, followed by Mebendazole, Praziquantel, and Niclosomide, in that order. The most commonly prescribed medicines for the treatment of taeniasis were albendazole and mebendazole. The discovery highlights the importance of cysticercosis and taeniasis in terms of both economics and public health. To reduce the impact of this parasite, special focus should be paid to raising public awareness and conducting thorough routine meat inspections.